The objective of this proposal is to identify antibodies which might represent correlated of protective immunity in HIV-1. It is possible that in depth studies of long term survivors of HIV-1 infection who manifest unusually strong parameters of antiviral immunity will provide information on which immune responses are protective. Our goal will be to isolate and characterize human monoclonal antibodies from a cohort of long-term survivors of HIV infection whose sera contain broad and potent serum neutralizing antibodies against primary HIV-1 isolates. Antibodies will also be derived from a subset of HIV-1 seroconverter patients who produce equally effective neutralizing antibodies to primary viruses. An underlying hypothesis is that an analysis of the total group of HMAbs derived from these subjects will reveal what kinds of antibodies account for neutralization of primary HIV-1 isolates. We believe that this approach lead to a better understanding of the correlates of protective immunity to HIV infection. We have developed new antibody screening methods which efficiently detect antibodies to envelope glycoproteins from autologous and heterologous primary isolates. In addition, a major effort will be directed toward the development of assays which will detect antibodies reacting with oligomeric envelope glycoproteins of primary viruses, since certain neutralization epitopes may be preferentially or uniquely exposed on oligomeric envelope structures on infectious virions. This type of antibody might be missed if we rely solely on assays utilizing solubilized monomeric glycoproteins. We will test all monoclonal antibodies that we isolate for virus neutralization and characterize their epitopes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI024030-11
Application #
2442436
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Project Start
1987-04-01
Project End
2000-06-30
Budget Start
1997-07-01
Budget End
1998-06-30
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Tulane University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Tuen, Michael; Visciano, Maria Luisa; Chien Jr, Peter C et al. (2005) Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation. Eur J Immunol 35:2541-51
Xiang, Shi-Hua; Farzan, Michael; Si, Zhihai et al. (2005) Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody. J Virol 79:6068-77
Decker, Julie M; Bibollet-Ruche, Frederic; Wei, Xiping et al. (2005) Antigenic conservation and immunogenicity of the HIV coreceptor binding site. J Exp Med 201:1407-19
Mechulam, Alain; Cerutti, Martine; Pugniere, Martine et al. (2005) Highly conserved beta16/beta17 beta-hairpin structure in human immunodeficiency virus type 1 YU2 gp120 is critical for CCR5 binding. J Mol Med 83:542-52
Robinson, James E; Elliott, Debra Holton; Martin, Effie A et al. (2005) High frequencies of antibody responses to CD4 induced epitopes in HIV infected patients started on HAART during acute infection. Hum Antibodies 14:115-21
Liao, Hua-Xin; Alam, S Munir; Mascola, John R et al. (2004) Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) Env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins. J Virol 78:5270-8
Ellis, Brett R; Munene, Elephas; Elliott, Debra et al. (2004) Seroprevalence of simian immunodeficiency virus in wild and captive born Sykes' monkeys (Cercopithecus mitis) in Kenya. Retrovirology 1:34
Cavacini, Lisa; Duval, Mark; Song, Leslie et al. (2003) Conformational changes in env oligomer induced by an antibody dependent on the V3 loop base. AIDS 17:685-9
Pincus, Seth H; Fang, Hua; Wilkinson, Royce A et al. (2003) In vivo efficacy of anti-glycoprotein 41, but not anti-glycoprotein 120, immunotoxins in a mouse model of HIV infection. J Immunol 170:2236-41
Raja, Aarti; Venturi, Miro; Kwong, Peter et al. (2003) CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5. J Virol 77:713-8

Showing the most recent 10 out of 48 publications